Strata Critical Medical (SRTA) Profit After Tax (2019 - 2026)

Strata Critical Medical has disclosed Profit After Tax across 8 years of filings, most recently posting $2.4 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 168.77% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $112.1 million (up 563.17% YoY), while the FY2025 annual figure was $41.3 million, up 355.84% from the prior year.
• Profit After Tax declined to $2.4 million in Q1 2026, from $56.0 million in the prior quarter.
• Over the last five years, Profit After Tax for SRTA reached as high as $57.4 million in Q3 2025 and fell as low as -$33.9 million in Q4 2023.
• The 5-year median for Profit After Tax is -$4.0 million (2024), against an average of -$142062.5.
• Annual changes were most pronounced in 2024 — Profit After Tax slumped 776.12% — and 2025, when it jumped 3038.38%.
• A 5-year view of Profit After Tax shows it stood at -$27.3 million in 2022, then decreased by 24.51% to -$33.9 million in 2023, then surged by 78.11% to -$7.4 million in 2024, then jumped by 854.04% to $56.0 million in 2025, then sank by 95.71% to $2.4 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $2.4 million, $56.0 million, and $57.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.